Physician
Providence Health & Services - Oregon
Providence Health & Services - Oregon was paid $20.12M by Medicaid between Jan 2018 and Nov 2024, across 65 billing codes. Its largest line is 99285, emergency room visit (most serious) — 35% of everything it billed.
33Billing provider infoPROVIDENCE HEALTH & SERVICES - OREGON
NEWBERG, OR 97132
NEWBERG, OR 97132
33aNPI1952482275assigned 10/17/2006
33bProvider typeAnesthesiology Physician
28Total paid$20.12M
24GClaims177,310
24DCodes billed65
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Anesthesiology Physician providers in Oregon
Rank by total paid#4 of 43
Median peer was paid$94K
This provider vs. median215×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,781 | $2.57M | |
| 2019 | 26,324 | $2.03M | |
| 2020 | 20,202 | $1.94M | |
| 2021 | 26,633 | $2.76M | |
| 2022 | 28,559 | $3.35M | |
| 2023 | 27,390 | $4.04M | |
| 2024incomplete | 17,421 | $3.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 35% | 12,702 | 11,331 | $7.04M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 29% | 16,084 | 14,064 | $5.83M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 17,035 | 14,841 | $4.42M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.0% | 8,918 | 8,153 | $613K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.0% | 8,183 | 7,682 | $610K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 2,848 | 2,620 | $296K |
| 80053 | Comprehensive metabolic panel | 1.2% | 27,133 | 24,999 | $247K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 28,981 | 26,697 | $192K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,750 | 3,401 | $132K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,566 | 2,354 | $109K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,546 | 2,366 | $85K |
| 81001 | <1% | 11,097 | 10,345 | $84K |
53 more codes
| 84484 | <1% | 3,713 | $83K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,748 | $48K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,348 | $43K |
| 83690 | <1% | 2,256 | $33K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 52 | $27K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,138 | $27K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 953 | $24K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 853 | $20K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,394 | $18K |
| 81025 | <1% | 788 | $15K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 458 | $10K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 639 | $10K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 57 | $9K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 333 | $9K |
| 80061 | Lipid panel | <1% | 776 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 148 | $8K |
| 83605 | <1% | 504 | $8K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 27 | $7K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 59 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 822 | $6K |
| 92567 | <1% | 113 | $6K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 657 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 133 | $4K |
| 92557 | <1% | 26 | $3K | |
| 87631 | <1% | 46 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 14 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 26 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 30 | $2K |
| 86140 | <1% | 352 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 54 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 64 | $2K |
| 82607 | <1% | 151 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 63 | $1K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 12 | $1K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 19 | $1K |
| 84439 | <1% | 85 | $995.33 | |
| 85652 | <1% | 235 | $690.53 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 79 | $523.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 12 | $494.09 |
| 84703 | <1% | 53 | $433.35 | |
| 82947 | <1% | 130 | $379.44 | |
| J2704 | Injection, propofol, 10 mg | <1% | 13 | $349.27 |
| 96376 | <1% | 12 | $335.72 | |
| 85027 | <1% | 172 | $316.71 | |
| 82247 | <1% | 76 | $264.82 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $177.58 |
| 84460 | <1% | 32 | $127.72 | |
| 84450 | <1% | 32 | $124.93 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 12 | $78.96 |
| 83735 | <1% | 13 | $74.40 | |
| 80305 | <1% | 12 | $63.19 | |
| 84100 | <1% | 13 | $55.20 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 3,648 | $1.73 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS)
Parent organizationPROVIDENCE HEALTH & SERVICES - OREGON
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.